Cancer News and Research

RSS
Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.
Targeted Y Chromosome Deletions Disrupt Key Cellular Immune Response Pathways

Targeted Y Chromosome Deletions Disrupt Key Cellular Immune Response Pathways

Oncogene-Induced Senescence Exhibits Dual Role in Tumor Suppression and Progression

Oncogene-Induced Senescence Exhibits Dual Role in Tumor Suppression and Progression

Study Establishes Immune Cell Trafficking as Viable Alzheimer's Target

Study Establishes Immune Cell Trafficking as Viable Alzheimer's Target

Study Links OCA2 Gene Mutations to Non-Melanin Ocular Developmental Defects

Study Links OCA2 Gene Mutations to Non-Melanin Ocular Developmental Defects

Single-Cell Sequencing Confirms Epigenetic Remodeling Across Diverse Cardiac Cell Types

Single-Cell Sequencing Confirms Epigenetic Remodeling Across Diverse Cardiac Cell Types

Post-Translational Modification Crosstalk Regulates Oncogenic Protein Stability and Activity

Post-Translational Modification Crosstalk Regulates Oncogenic Protein Stability and Activity

Neutrophil Activation by NMU Blocks Cytotoxic T Cell Tumor Infiltration

Neutrophil Activation by NMU Blocks Cytotoxic T Cell Tumor Infiltration

Cancer Cells Hijack Embryonic Repair Mechanisms to Seed Liver Metastases

Cancer Cells Hijack Embryonic Repair Mechanisms to Seed Liver Metastases

Multi-Receptor Blocking Achieves Superior Antifibrotic Response Over Single-Receptor Inhibition

Multi-Receptor Blocking Achieves Superior Antifibrotic Response Over Single-Receptor Inhibition

Cancer-Associated Fibroblasts Construct Physical Barriers Limiting Antitumor T Cell Infiltration

Cancer-Associated Fibroblasts Construct Physical Barriers Limiting Antitumor T Cell Infiltration

Marine Carbohydrate Therapeutics: From Structural Diversity to Clinical Translation

Marine Carbohydrate Therapeutics: From Structural Diversity to Clinical Translation

Scientists Discover Why High Levels of the Amino Acid Cysteine Are Toxic to Cells

Scientists Discover Why High Levels of the Amino Acid Cysteine Are Toxic to Cells

Study Uncovers Two-Protein Repair Mechanism Preserving Circular ecDNA Stability

Study Uncovers Two-Protein Repair Mechanism Preserving Circular ecDNA Stability

Researchers Simulate Microgravity to Isolate Gravity's Impact on Human Chromatin

Researchers Simulate Microgravity to Isolate Gravity's Impact on Human Chromatin

KAIST Researchers Develop NUDGE to Steer Cell States Without Permanent Alteration

KAIST Researchers Develop NUDGE to Steer Cell States Without Permanent Alteration

Mitochondrial RNA May Explain How Tumors Become Resistant to Immunotherapy

Mitochondrial RNA May Explain How Tumors Become Resistant to Immunotherapy

Blocking Mitochondrial Iron Transport Protects Cells Against Elevated Cysteine Toxicity

Blocking Mitochondrial Iron Transport Protects Cells Against Elevated Cysteine Toxicity

Tumor Suppressor Pathways Remain Intact but Hyperactive During Progressive Tissue Aging

Tumor Suppressor Pathways Remain Intact but Hyperactive During Progressive Tissue Aging

Obesity May Remove a Natural Defense Against Breast Cancer

Obesity May Remove a Natural Defense Against Breast Cancer

Researchers Reveal How p53 Tumor-Suppressor Protein Hide From T Cells

Researchers Reveal How p53 Tumor-Suppressor Protein Hide From T Cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.